# clm_7AF7234E1826

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_net_income  
value: -30,522,000 United States dollar  
valid_from: 2010-03-31  
valid_to: 2010-06-30  
published: 2011-05-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_620FABA54C3D  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly net income: -30,522,000 United States dollar", as of 2010-03-31 (until 2010-06-30). Claim clm_7AF7234E1826, https://asof.is/claim/clm_7AF7234E1826, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677411001105/0001206774-11-001105-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q1 FY2011, filed 2011-05-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000120677411001105/0001206774-11-001105-index.htm (primary, SEC EDGAR 10-Q Q1 FY2011, published 2011-05-03)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | -1,015,000 United States dollar | valid 2009-09-30 to 2010-03-31 | conf 0.95 | superseded | superseded_by [clm_7AF7234E1826](/claim/clm_7AF7234E1826.md) | [clm_AFED42FED572](/claim/clm_AFED42FED572.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.